£495.00

The 2023-2028 Outlook for Non-Hodgkin Lymphoma in China

Price data checked 7 days ago

View at Amazon

Price History & Forecast

Last 84 days • 84 data points (No recent data available)

Historical
Generating forecast...
£495.00 £470.25 £480.15 £490.05 £499.95 £509.85 £519.75 26 January 2026 15 February 2026 08 March 2026 29 March 2026 19 April 2026

Price Distribution

Price distribution over 84 days • 1 price levels

Days at Price
84 days 0 21 42 63 84 £495 Days at Price

Price Analysis

Most common price: £495 (84 days, 100.0%)

Price range: £495 - £495

Price levels: 1 different prices over 84 days

Product Specifications
Format
paperback
ASIN
B0BBJWJJK4
Category
Books > Subjects
Domain
Amazon UK
Release Date
16 August 2022
Listed Since
26 August 2022

Similar Products You Might Like

The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in China
99% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in China

£495.00 12 Jan 2026
The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in China
99% match

The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in China

£495.00 24 Jan 2026
The 2023-2028 Outlook for Lymphoma Treatments in China
98% match

The 2023-2028 Outlook for Lymphoma Treatments in China

£495.00 23 Jan 2026
The 2023-2028 Outlook for Multiple Myeloma Treatments in China
97% match

The 2023-2028 Outlook for Multiple Myeloma Treatments in China

£495.00 25 Jan 2026
The 2023-2028 Outlook for Head and Neck Oncology Nutrition in China
97% match

The 2023-2028 Outlook for Head and Neck Oncology Nutrition in China

£495.00 20 Mar 2026
The 2023-2028 Outlook for Natural Killer Cell Therapeutics in China
97% match

The 2023-2028 Outlook for Natural Killer Cell Therapeutics in China

£495.00 12 Jan 2026
The 2023-2028 Outlook for Cancer Screenings in China
97% match

The 2023-2028 Outlook for Cancer Screenings in China

£495.00 16 Dec 2025
The 2023-2028 Outlook for Non-Hodgkin Lymphoma in Japan
96% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma in Japan

£495.00 27 Jan 2026
The 2023-2028 Outlook for Neuroendocrine Tumor Treatments in China
96% match

The 2023-2028 Outlook for Neuroendocrine Tumor Treatments in China

£495.00 20 Jan 2026
The 2023-2028 Outlook for Brain Tumor Diagnosis and Treatments in China
96% match

The 2023-2028 Outlook for Brain Tumor Diagnosis and Treatments in China

£495.00 11 Jan 2026
The 2023-2028 Outlook for Primary Brain Tumor Diagnosis and Treatments in China
96% match

The 2023-2028 Outlook for Primary Brain Tumor Diagnosis and Treatments in China

£495.00 12 Mar 2026
The 2023-2028 World Outlook for Non-Hodgkin Lymphoma
96% match

The 2023-2028 World Outlook for Non-Hodgkin Lymphoma

Out of Stock 07 Jan 2026
The 2023-2028 Outlook for Genomics in Cancer Care in China
96% match

The 2023-2028 Outlook for Genomics in Cancer Care in China

£495.00 04 Feb 2026
The 2023-2028 Outlook for Prostate Cancer Nuclear Medicine Diagnostics in China
96% match

The 2023-2028 Outlook for Prostate Cancer Nuclear Medicine Diagnostics in China

£495.00 14 Jan 2026
The 2023-2028 Outlook for Cancer Supportive Care Drugs in China
96% match

The 2023-2028 Outlook for Cancer Supportive Care Drugs in China

£495.00 08 Mar 2026
The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in China
96% match

The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in China

£495.00 20 Mar 2026
The 2023-2028 Outlook for Chemotherapy and Antibody Combination Antibody Therapies in China
96% match

The 2023-2028 Outlook for Chemotherapy and Antibody Combination Antibody Therapies in China

£495.00 07 Jan 2026
The 2023-2028 Outlook for Basal Cell Carcinoma Surgeries in China
96% match

The 2023-2028 Outlook for Basal Cell Carcinoma Surgeries in China

£495.00 29 Jan 2026
The 2023-2028 Outlook for Oncolytic Virus Immunotherapies in China
96% match

The 2023-2028 Outlook for Oncolytic Virus Immunotherapies in China

£495.00 11 Jan 2026
The 2023-2028 Outlook for Bile Duct Cancer (Cholangiocarcinoma) Treatments in China
96% match

The 2023-2028 Outlook for Bile Duct Cancer (Cholangiocarcinoma) Treatments in China

£495.00 25 Jan 2026
The 2023-2028 Outlook for Glioblastoma Multiforme Drugs in China
96% match

The 2023-2028 Outlook for Glioblastoma Multiforme Drugs in China

£495.00 10 Mar 2026
The 2023-2028 Outlook for Immunology Therapeutics in China
96% match

The 2023-2028 Outlook for Immunology Therapeutics in China

£495.00 12 Jan 2026
The 2023-2028 Outlook for Basal Cell Carcinoma Treatments in China
96% match

The 2023-2028 Outlook for Basal Cell Carcinoma Treatments in China

£495.00 08 Jan 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma for US Zip Codes
96% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma for US Zip Codes

£490.00 01 Feb 2026